$Nxera Pharma (4565.JP)$
$Neurocrine Biosciences (NBIX.US)$
An interesting fact is that ネクセラファーマ’s stork price has been collaborating with NBIX for a while. But, besides that the price is even lower compare to the time before M&A and the launch of the new medicine, which is ridiculous. I have confidence that the current price will be fixed and hope we can overcome the darkness before the dawn. Let’s meet at the top guys :-)